Role of Chemokine Receptors in Cancer Metastasis

Displaying 1 - 4 of 4CSV
Qian, J., Ryeom, S., Daugherty, B. L., Lederman, S., & Wang, T. C. (2023). 481 A CXCR4 partial agonist TFF2-MSA sensitized advanced gastric cancer to PD-1 blockade by systematically reducing PMN-MDSC accumulation, immunosuppression, and generation in bone marrow. Regular and Young Investigator Award Abstracts. https://doi.org/10.1136/jitc-2023-sitc2023.0481
Publication Date
Klausz, K., Gehlert, C. L., Krohn, S., Winterberg, D., Lustig, M., Boje, A. S., Besse, L., Besse, A., Driessen, C., Peipp, M., & Gramatzki, M. (2023). P-198 Impact of blocking the CD47 axis on phagocytosis of myeloma cells treated with CD38 antibodies and proteasome inhibitors. Clinical Lymphoma Myeloma and Leukemia, 23, S144–S145. https://doi.org/10.1016/s2152-2650(23)01816-5
Publication Date
Ho, P., Melms, J. C., Rogava, M., Frangieh, C. J., Poźniak, J., Shah, S. B., Walsh, Z., Kyrysyuk, O., Amin, A. D., Caprio, L., Fullerton, B. T., Soni, R. K., Ager, C. R., Biermann, J., Wang, Y., Khosravi-Maharlooei, M., Zanetti, G., Mu, M., Fatima, H., … Izar, B. (2023). The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity. Cancer Cell, 41(7), 1207-1221.e12. https://doi.org/10.1016/j.ccell.2023.05.014
Publication Date
Mysore, V., Tahir, S., Furuhashi, K., Arora, J., Rosetti, F., Cullere, X., Yazbeck, P., Sekulic, M., Lemieux, M. E., Raychaudhuri, S., Horwitz, B. H., & Mayadas, T. N. (2022). Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2. Journal of Experimental Medicine, 219(5). https://doi.org/10.1084/jem.20210562
Publication Date